+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Visual function maintenance

Visual function maintenance encompasses a range of strategies and interventions aimed at preserving and optimizing an individual's sight and ocular health throughout their lifespan. This includes regular ophthalmic examinations, early detection and management of ocular diseases (e.g., glaucoma, macular degeneration, cataracts), refractive error correction, nutritional support, and protection against environmental factors. Proactive measures are crucial for sustaining visual acuity, field, and overall quality of life.
Catalog No Product Description CAS No. Purity Structural Formula
BP5206
Avenanthramide B
Avenanthramide B is a monohydroxybenzoic acid resulting from the formal condensation of the carboxy group of ferulic acid with the amino group of 2-amino-5-hydroxybenzoic acid. It is an oat phytoalexin produced in response to pathogen attack and elicitation. It has a role as a phytoalexin, an antineoplastic agent and an apoptosis inducer. It is a secondary carboxamide, a member of cinnamamides, a monomethoxybenzene, a monohydroxybenzoic acid, a member of phenols and an amidobenzoic acid.
108605-69-2 98% Avenanthramide B
BP0298
Byakangelicin
Byakangelicin is found in extracts of the root of Angelica dahurica, used in Korea and China as a traditional medicine to treat colds, headache and toothache, it can inhibit the effects of sex hormones, it may increase the catabolism of endogenous hormones, it induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes. Byakangelicin is effective for the treatment of sugar cataracts and diabetic neuropathy in rats. Byakangelicin could as insecticides and insect antifeedant for the control of Lepidoptera and Homoptera showed a significant effect.
482-25-7 98% Byakangelicin
BP5305
Isogambogenic acid
Isogambogenic acid inhibits angiogenesis and may be a viable drug candidate in anti-angiogenesis therapy. Isogambogenic acid exhibits an anticancer effect by inducing autophagy-dependent cell death in NSCLC cells, which may be an effective chemotherapeutic agent that can be used against NSCLC in a clinical setting.
887923-47-9 98% Isogambogenic acid